Encompass Health (NYSE:EHC) Rating Reiterated by Raymond James

Encompass Health (NYSE:EHC - Get Free Report)'s stock had its "strong-buy" rating reissued by analysts at Raymond James in a research note issued to investors on Friday, Benzinga reports. They currently have a $95.00 price target on the stock, up from their prior price target of $85.00. Raymond James' target price would suggest a potential upside of 15.21% from the stock's previous close.

EHC has been the subject of a number of other reports. Barclays increased their target price on Encompass Health from $101.00 to $108.00 and gave the stock an "overweight" rating in a report on Thursday. Truist Financial increased their price target on Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research report on Friday, February 9th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Stephens reiterated an "overweight" rating and issued a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Finally, Mizuho increased their price objective on Encompass Health from $93.00 to $95.00 and gave the company a "buy" rating in a research report on Thursday. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $86.56.

Encompass Health Stock Performance

Shares of NYSE EHC traded down $0.27 during trading hours on Friday, hitting $82.46. 706,619 shares of the company's stock were exchanged, compared to its average volume of 672,948. Encompass Health has a 1-year low of $57.55 and a 1-year high of $85.84. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28. The stock has a market capitalization of $8.26 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.53 and a beta of 0.94. The company's 50-day moving average price is $78.07 and its 200-day moving average price is $70.76.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to analysts' expectations of $1.27 billion. Encompass Health had a return on equity of 18.48% and a net margin of 7.60%. The firm's revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.88 EPS. On average, sell-side analysts expect that Encompass Health will post 3.96 earnings per share for the current fiscal year.

Institutional Trading of Encompass Health

Hedge funds have recently added to or reduced their stakes in the business. AE Wealth Management LLC raised its stake in shares of Encompass Health by 26.8% in the 3rd quarter. AE Wealth Management LLC now owns 6,381 shares of the company's stock valued at $429,000 after purchasing an additional 1,350 shares during the period. Oak Thistle LLC bought a new position in shares of Encompass Health in the 3rd quarter valued at about $814,000. Linden Thomas Advisory Services LLC grew its holdings in shares of Encompass Health by 22.1% in the 3rd quarter. Linden Thomas Advisory Services LLC now owns 15,220 shares of the company's stock valued at $1,022,000 after acquiring an additional 2,754 shares in the last quarter. Copeland Capital Management LLC grew its holdings in shares of Encompass Health by 0.5% in the 3rd quarter. Copeland Capital Management LLC now owns 1,277,690 shares of the company's stock valued at $85,810,000 after acquiring an additional 6,009 shares in the last quarter. Finally, Tectonic Advisors LLC bought a new position in shares of Encompass Health in the 3rd quarter valued at about $343,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.